Tezepelumab Completed Phase 3 Trials for Asthma Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03706079Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
NCT03968978Tezepelumab Home Use Study
NCT03406078Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
NCT03347279Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma